Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian E Smith

Showing results (1-10 of 132) with videos related to

Pageof 14
Sort By:
Breast (Edinburgh, Scotland)|December 9, 2003
Hormonal therapy: introductionIan E Smith
The Journal of Steroid Biochemistry and Molecular Biology|November 19, 2003
Letrozole versus tamoxifen in the treatment of advanced breast cancer and as neoadjuvant therapyIan E Smith
Seminars in Oncology|June 27, 2006
Overview of gemcitabine activity in advanced breast cancerIan E Smith
Breast Cancer Research : BCR|December 25, 2009
Do BIG1-98 and ZOFAST demand a change in guidelines for endocrine therapy?Ian E Smith
Breast (Edinburgh, Scotland)|December 9, 2004
Aromatase inhibitors--extending the benefits of adjuvant therapy beyond tamoxifenIan E Smith
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2017
Reply to R. Goncalves et alIan E Smith
Seminars in Oncology|February 22, 2005
Aromatase inhibitors in early breast cancer therapyIan E Smith
Lancet (London, England)|January 18, 2006
Trastuzumab for early breast cancerIan E Smith
Breast Cancer Research : BCR|December 25, 2009
Debate: tailored targeted therapy for all--a realistic and worthwhile objective? Introduction to Session 2Ian E Smith
Lancet (London, England)|September 21, 2002
New drugs for breast cancerIan E Smith
Pageof 14

Showing results (1-10 of 132) with videos related to

Sort By:
Pageof 14
Breast (Edinburgh, Scotland)|December 9, 2003
Hormonal therapy: introductionIan E Smith
The Journal of Steroid Biochemistry and Molecular Biology|November 19, 2003
Letrozole versus tamoxifen in the treatment of advanced breast cancer and as neoadjuvant therapyIan E Smith
Seminars in Oncology|June 27, 2006
Overview of gemcitabine activity in advanced breast cancerIan E Smith
Breast Cancer Research : BCR|December 25, 2009
Do BIG1-98 and ZOFAST demand a change in guidelines for endocrine therapy?Ian E Smith
Breast (Edinburgh, Scotland)|December 9, 2004
Aromatase inhibitors--extending the benefits of adjuvant therapy beyond tamoxifenIan E Smith
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2017
Reply to R. Goncalves et alIan E Smith
Seminars in Oncology|February 22, 2005
Aromatase inhibitors in early breast cancer therapyIan E Smith
Lancet (London, England)|January 18, 2006
Trastuzumab for early breast cancerIan E Smith
Breast Cancer Research : BCR|December 25, 2009
Debate: tailored targeted therapy for all--a realistic and worthwhile objective? Introduction to Session 2Ian E Smith
Lancet (London, England)|September 21, 2002
New drugs for breast cancerIan E Smith
Pageof 14